LSS and breast carcinoma: Inhibiting CHOL biosynthesis using lanosterol synthase (LSS) inhibitor RO48‐8071 (RO) significantly inhibited hormone‐dependent and castration‐resistant PCa cells in vitro and PCa tumor growth in in vivo tumor xenograft mice models [11] and breast cancer [12].